Correction: Pharmacologic targeting of the PI3K/mTOR pathway controls release of angioregulators from primary human acute myeloid leukemia cells and their neighboring stromal cells

Benzer Materyaller

• Pharmacological targeting of the PI3K/mTOR pathway alters the release of angioregulatory mediators both from primary human acute myeloid leukemia cells and their neighboring stromal cells
  Yazar:: Reikvam, Håkon, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• Clonal Heterogeneity Reflected by PI3K-AKT-mTOR Signaling in Human Acute Myeloid Leukemia Cells and Its Association with Adverse Prognosis
  Yazar:: Nepstad, Ina, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• Resistance to the Antiproliferative In Vitro Effect of PI3K-Akt-mTOR Inhibition in Primary Human Acute Myeloid Leukemia Cells Is Associated with Altered Cell Metabolism
  Yazar:: Nepstad, Ina, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• The PI3K-Akt-mTOR Signaling Pathway in Human Acute Myeloid Leukemia (AML) Cells
  Yazar:: Nepstad, Ina, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Effects of insulin and pathway inhibitors on the PI3K-Akt-mTOR phosphorylation profile in acute myeloid leukemia cells
  Yazar:: Nepstad, Ina, ve diğerleri
  Baskı/Yayın Bilgisi: (2019)